metaLead
Developing a potent treatment for metal poisoning
Total raised
€1.2M
€1,223,836
Funding rounds
2
Investors
2
distinct backers
Active since
2023-03
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-06 | Other | €1.1M | UZH Life Sciences Fund (LSF) | View deal → |
| 2023-03-10 | Other | €153k | Venture Kick | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy